血液病患者异基因造血干细胞移植后Rh血型转变研究*

doi:10.3969/j.issn.1671-2587.2024.02.011

临床输血与检验 ›› 2024, Vol. 26 ›› Issue (2): 230-235.DOI: 10.3969/j.issn.1671-2587.2024.02.011

血液病患者异基因造血干细胞移植后Rh血型转变研究^*

童欣欣, 钟明璐, 黄慧瑛, 邓晖, 黄建云, 魏亚明

广州市第一人民医院输血医学科,广东广州 510180

收稿日期:2024-01-24 出版日期:2024-04-20 发布日期:2024-04-23
通讯作者: 魏亚明,主要从事细胞治疗和输血免疫研究,（E-mail）eywym@scut.edu.cn。
作者简介:童欣欣,主要从事输血免疫学研究,（E-mail）eytongxx@scut.edu.cn。
基金资助:
*本课题受广州市临床重大技术（No.2019ZD18）、广东省企联合面上项目（No.2021A1515220044）、广州市医药卫生一般引导项目（No.20221A011008）资助

Transformation of Rh Blood Group in Patients with Blood Diseases Treated with Allogeneic Hematopoietic Stem Cell Transplantation

TONG Xinxin, ZHONG Minglu, HUANG huiying, DENG Hui, HUANG Jianyun, WEI Yaming

Department of Blood Transfusion, Guangzhou First People's Hospital, Guangzhou 510180

Received:2024-01-24 Online:2024-04-20 Published:2024-04-23

摘要/Abstract

摘要： 目的检测血液病患者造血干细胞移植（HSCT）前供、受者及移植后患者的Rh血型抗原C、c、E、e,探究受者Rh血型抗原转变为供者Rh血型抗原C、c、E、e转变时间与过程。方法收集HSCT前供、受者以及移植后患者的抗凝全血标本,用微柱凝胶卡检测ABO血型、Rh血型,统计分析并比较ABO、Rh血型抗原转变与时间。结果排除红细胞输注的影响,58例HSCT患者Rh血型抗原C、c、E、e完全转变为供者的Rh血型抗原所需时间为（57.81±8.99） d,患者的年龄和血液病种类影响Rh血型抗原转换时间,性别、移植方式和供受者ABO血型相合性对Rh抗原转变时间无影响。移植后第3周部分患者开始出现少量供者红细胞,第4周开始检测到混和嵌合状态,第7~10周Rh血型抗原完全转变。此外,比较25例供、受者ABO血型和Rh血型均不相同的HSCT患者的Rh血型抗原转变时间和ABO血型转变时间,Rh血型抗原转变时间较ABO更短,差异具有统计学意义。结论定期检测HSCT患者移植后Rh血型抗原可以作为辅助判断移植效果的指标之一,对HSCT患者移植后输注Rh血型相容性的红细胞具有指导意义。

关键词: 异基因造血干细胞移植, Rh血型抗原, 转变时间

Abstract: Objective To detect the Rh antigens C, c, E, e in hematopoietic stem cell transplantation (HSCT) patients with blood diseases and donors before and after transplantation, and analyze the time and process of the conversion of Rh blood type from recipients to donor Rh antigens C, c, E, e. Methods Anticoagulant blood samples were collected from patients and donors before and after transplantation for detection of antigen transformation by using microcolumn agglutination card, ABO and Rh antigen conversion time were analyzed and compared. Results Excluding the effects of red blood cell transfusions, the average time length of 58 HSCT patients was 57.81±8.99 days that Rh antigens C, c, E, e completely transformed from recipient to donor after transplantation. Patient age and hematological classification showed impact on the time of Rh antigens conversion, while the gender, ABO blood group compatibility, as well as transplant mode showed no influence on the Rh antigen conversion time. Donor's red blood cells appeared in some patients as early as 3rd week after transplantation, mixed chimerism of donor and patient was detected from the 4th week, and the Rh blood group antigens were found to be completely transformed from the 7th to the 10th week. In addition, both Rh and ABO blood group antigen transition time in 25 HSCT patients those Rh and ABO blood type between patients and donors were different were analyzed, and the Rh transition time was shorter than ABO, and its difference was statistically significant. Conclusion Regular typing of Rh blood group antigen is necessary for patients after HSCT transplantation, and these Rh antigens are indicators to judge transplantation treatment effect, and they also show a significance of guiding transfusion of Rh blood group compatible red blood cells in HSCT patients after transplantation.

Key words: Allogeneic hematopoietic stem cell transplantation, Rh blood group antigen, Transition time

中图分类号:

R457.7R457.1⁺1

童欣欣, 钟明璐, 黄慧瑛, 邓晖, 黄建云, 魏亚明. 血液病患者异基因造血干细胞移植后Rh血型转变研究^*[J]. 临床输血与检验, 2024, 26(2): 230-235.

TONG Xinxin, ZHONG Minglu, HUANG huiying, DENG Hui, HUANG Jianyun, WEI Yaming. Transformation of Rh Blood Group in Patients with Blood Diseases Treated with Allogeneic Hematopoietic Stem Cell Transplantation[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 230-235.

参考文献

[1] JUNGBAUER C.Routine use of DNA testing for red cell antigens in blood centres[J].Transfus Apher Sci,2011,45(1):61-68.
[2] BAKHSHANDEH Z,AMIRIZADEH N,MAGHSOODLU M,et al.Developing a databank for multiple transfusion patients:Rh antigen and phenotype distribution among 3000 regular blood donors in Iran[J].Transfus Apher Sci,2021,60(3):103124.
[3] 倪修文,陈涛,罗振,等.Rh血型系统5种分型抗原同型输血在血液病患者精准化输血治疗中的价值研究[J].中国卫生检验杂志,2023,33(14):1706-1709.
[4] WOREL N.ABO-mismatched allogeneic hematopoietic stem cell transplantation[J].Transfus Med Hemother,2016,43(1):3-12.
[5] XU L P,LU P H,WU D P,et al.Hematopoietic stem cell transplantation activity in China 2019:a report from the Chinese Blood and Marrow Transplantation Registry Group[J].Bone Marrow Transplant,2021,56(12):2940-2947.
[6] CHEN Y,WAN X J,CAO Y,et al.ABO incompatibility does not affect transfusion requirements or clinical outcomes of unrelated cord blood transplantation after myeloablative conditioning for haematological malignancies[J].Blood Transfus,2022,20(2):156-167.
[7] CARRERAS E, DUFOUR C, MOHTY M, et al.The EBM T Handbook:Hematopoietic Stem Cell Transplantation and Cellular Therapies[M].Cham:Springer International Publishing,2019.
[8] SHIINA T,HOSOMICHI K,INOKO H,et al.The HLA genomic loci map:expression,interaction,diversity and disease[J].J Hum Genet,2009,54(1):15-39.
[9] ABOi-HSCT血型检测与血液成分输注专家共识编写组.ABO血型不合异基因造血干细胞移植受者血型检测与血液成分输注专家共识[J].中国输血杂志,2023,36(11):971-977.
[10] LUTEN M,ROERDINKHOLDER-STOELWINDER B,SCHAAP N P M,et al.Survival of red blood cells after transfusion:a comparison between red cells concentrates of different storage periods[J].Transfusion,2008,48(7):1478-1485.
[11] SOLVES P,CARPIO N,CARRETERO C,et al.ABO incompatibility does not influence transfusion requirements in patients undergoing single-unit umbilical cord blood transplantation[J].Bone Marrow Transplant,2017,52(3):394-399.
[12] KLUMPP T R,HERMAN J H,ULICNY J,et al.Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation[J].Bone Marrow Transplant,2006,38(9):615-620.
[13] 异基因造血干细胞移植临床输血专家共识起草专家组.异基因造血干细胞移植临床输血专家共识[J].临床输血与检验,2023,25(5):586-593.
[14] 于天华,遇红梅,梁海英,等.5050名患者Rh分型及不规则抗体鉴定结果分析[J].中国输血杂志,2012,25(8):756-758.
[15] BACIGALUPO A.How I treat acquired aplastic anemia[J].Blood,2017,129(11):1428-1436.
[16] GYURKOCZA B,SANDMAIER B M.Conditioning regimens for hematopoietic cell transplantation:one size does not fit all[J].Blood,2014,124(3):344-353.
[17] 许金华,李晓丰.ABO血型不合异基因造血干细胞移植后血型转换期的输血策略[J].中国组织工程研究,2015,19(6):913-917.
[18] TIWARI A K,SETYA D,AGGARWAL G,et al.Evaluation of new indigenous “point-of-care” ABO and Rh grouping device[J].J Lab Physicians,2018,10(1):80-84.
[19] 魏亚明,吕毅.基础输血学[M].北京: 人民卫生出版社,2011.
[20] 权军辉,张明刚,邵香,等.西安地区供受血者红细胞Rh表型匹配输注及追踪分析[J].临床输血与检验,2021,23(3):310-314.
[21] WESTHOFF C M.Blood group genotyping[J].Blood,2019,133(17):1814-1820.

血液病患者异基因造血干细胞移植后Rh血型转变研究^*

Transformation of Rh Blood Group in Patients with Blood Diseases Treated with Allogeneic Hematopoietic Stem Cell Transplantation

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	异基因造血干细胞移植临床输血专家共识起草专家组. 异基因造血干细胞移植临床输血专家共识[J]. 临床输血与检验, 2023, 25(5): 586-593.
[2]	江晓明, 杜平, 陈烨. Rh血型抗原CcEe在临床输血中的意义[J]. 临床输血与检验, 2018, 20(6): 648-650.
[3]	史恩祥, 鲁传东, 丁秀丽, 王茹燕, 徐然, 门蓓蕾. Rh血型配合性输注的重要性[J]. 临床输血与检验, 2017, 19(2): 182-184.